Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.
Even after Trump’s new deal, obesity drugs are still too expensive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback